| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |